Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Search sources

Showing 181–200 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

181

Human clinical studyPubMed · 1984Checked 2026-08-30

DSIP in withdrawal syndromes from alcohol and opiates

Reviews using this sourceDSIP

Sources behind the answers.

DSIP in withdrawal syndromes from alcohol and opiates

Opioid detoxification with DSIP: open clinical trial

Intravenous DSIP and a blood hormone change in people

FDA Global Substance Registration System record for ropocamptide (LL-37)

FDA Global Substance Registration System record for LL-37 amide

Human cathelicidin precursor processing to LL-37

Early randomized trial of topical LL-37 in venous leg ulcers

Later randomized trial of LL-37 in venous leg ulcers

Randomized study of topical LL-37 in diabetic foot ulcers

LL-37 melanoma study record (NCT02225366)

Engineered Lactococcus lactis producing recombinant LL-37 in COVID-19

Pharmacy Compounding Advisory Committee meeting planning

FDA substance record for P-21, P021, and P21

P21 learning, memory, and nerve-cell study in normal mice

Chronic P021 study in an Alzheimer-like mouse model

Early P021 study in an Alzheimer-like mouse model

P021 tau study in aged rats

P021 study in lab-grown human nerve cells and a mouse model

ClinicalTrials.gov intervention search for P021

NCBI Gene record for human CDKN1A, also called p21

How this list works